An agreement between attorneys general and major drug distributors increased scrutiny on medications for A.D.H.D., addiction, anxiety and pain. By Christina Jewett and Ellen Gabler The case ...

McKesson plans to grow its oncology platform by investing nearly $2.5 billion into a community oncology clinic operator’s business and administrative services arm. Announced Monday, the deal ...

McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Drug distributor McKesson will pay about $2.49 ...

Representatives for McKesson and Florida Cancer Specialists didn’t respond to requests for comment. Shares in Irving, Texas-based McKesson have risen 19% this year, giving it a market value of ...

McKesson said Monday it signed a definitive agreement to acquire a controlling stake in Community Oncology Revitalization Enterprise Ventures LLC, or Core Ventures, for $2.5 billion in cash.

Analyst Allen Lutz from Bank of America Securities maintained a Buy rating on McKesson (MCK – Research Report) and keeping the price target at $635.00. Allen Lutz has given his Buy rating due to ...

(Bloomberg) -- McKesson Corp. agreed to buy a controlling stake in an arm of Florida Cancer Specialists & Research Institute, a privately held operator of clinics. Most Read from Bloomberg Sydney ...

Aug 26 (Reuters) - Drug distributor McKesson (MCK.N), opens new tab said on Monday it would buy a controlling stake in community cancer center Florida Cancer Specialists & Research Institute's ...

The $2.49 billion cash purchase will give McKesson about 70% ownership of Community Oncology Revitalization Enterprise Ventures, LLC (Core Ventures). The $2.49 billion cash purchase will give ...

Florida Cancer Specialists & Research Institute is selling a controlling interest of a business unit to McKesson Corp. for $2.49 billion, according to an announcement from McKesson. The ...

McKesson to Buy Controlling Stake in Florida Cancer Specialists' Unit for About $2.5 Billion (Reuters) -Drug distributor McKesson said on Monday it would buy a controlling stake in community ...